Diversified Trust Co - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 246 filers reported holding HAEMONETICS CORP in Q3 2021. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Diversified Trust Co ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2022$991
-99.9%
12,596
-0.6%
0.04%
-2.4%
Q3 2022$938,000
+24.1%
12,666
+9.2%
0.04%
+31.2%
Q2 2022$756,000
+3.0%
11,595
-0.2%
0.03%
+23.1%
Q1 2022$734,000
+16.9%
11,615
-1.9%
0.03%
+23.8%
Q4 2021$628,000
-19.7%
11,837
+6.8%
0.02%
-25.0%
Q3 2021$782,000
+6.0%
11,081
+0.1%
0.03%
+3.7%
Q2 2021$738,000
+40.3%
11,073
-11.2%
0.03%
-50.0%
Q4 2013$526,000
+19.0%
12,475
+12.6%
0.05%
+14.9%
Q3 2013$442,00011,0750.05%
Other shareholders
HAEMONETICS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Iron Triangle Partners LP 330,000$36,633,0004.66%
BEACONLIGHT CAPITAL, LLC 156,395$17,361,0002.80%
Bridge City Capital, LLC 48,011$5,330,0001.77%
Summit Creek Advisors LLC 121,362$13,472,0001.61%
Sivik Global Healthcare LLC 25,000$2,775,0001.01%
ANCHOR CAPITAL ADVISORS LLC 412,218$45,760,0000.97%
MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income 69,655$7,732,0000.90%
Orbimed Advisors 852,000$94,581,0000.88%
LONDON CO OF VIRGINIA 1,057,738$117,420,0000.67%
WEXFORD CAPITAL LP 40,138$4,456,0000.66%
View complete list of HAEMONETICS CORP shareholders